about
Advances in iron chelation therapy: transitioning to a new oral formulation.Characterization of the hypercoagulable state in patients with sickle cell disease.Presentation and outcomes for children with bone marrow necrosis and acute lymphoblastic leukemia: a literature review.Sickle cell disease is associated with iron mediated hypercoagulability.Hybrid Statistical and Mechanistic Mathematical Model Guides Mobile Health Intervention for Chronic Pain.Challenges in Shifting Management Responsibility From Parents to Adolescents With Sickle Cell Disease.Understanding patterns and correlates of daily pain using the Sickle cell disease Mobile Application to Record Symptoms via Technology (SMART).Attitudes of Primary Care Physicians Toward Sickle Cell Disease Care, Guidelines, and Comanaging Hydroxyurea With a Specialist.Patients welcome the Sickle Cell Disease Mobile Application to Record Symptoms via Technology (SMART).Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.Utilizing a Novel Mobile Health "Selfie" Application to Improve Compliance to Iron Chelation in Pediatric Patients Receiving Chronic Transfusions.Characteristics of abdominal vein thrombosis in children and adults.Abstract Animations for the Communication and Assessment of Pain in Adults: Cross-Sectional Feasibility StudyPatient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic ReviewSevere fetal and neonatal hemolytic anemia due to a 198 kb deletion removing the complete β-globin gene clusterUsability and Feasibility of an mHealth Intervention for Monitoring and Managing Pain Symptoms in Sickle Cell Disease: The Sickle Cell Disease Mobile Application to Record Symptoms via Technology (SMART)Mobile health intervention for youth with sickle cell disease: Impact on adherence, disease knowledge, and quality of lifeUse of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility StudyImproving Pain Management in Patients with Sickle Cell Disease from Physiological Measures Using Machine Learning Techniques
P50
Q33879123-EFEC5A00-AE6C-4117-BCAE-DAD0CE433B68Q36328563-7B093988-8938-4379-B2A9-A6D9F39F15EEQ37937386-8CB3E635-841C-4F69-813E-1C867335305FQ38386253-08883E92-AE11-4671-A4B0-2266C664AB21Q38674698-BD72F720-4C63-4869-8B63-4805E3700770Q38838460-2F431379-42B3-4954-8340-2EE2510CD19EQ46047573-871ABDC7-B2F0-4D31-BC53-DC1C99FFEA44Q50597105-5CE9C581-4185-4E41-8599-F1FB67E46FC6Q50623258-6840A919-D27D-474D-AEE1-233CF5587B3DQ52719774-F2539FA4-77F7-4447-8D9D-8FEE8E111A88Q53567782-EA0D28CF-0863-423E-8BF0-D0E96256C984Q55664899-50265A52-3FDD-4779-B5E1-8AA341E0468FQ56516465-804BDCF4-85FF-409F-9C03-EB077FE50BB5Q57175362-B5A8B19A-A0CE-4620-B943-D00CDA1FD742Q57624698-BEB8FC38-B462-40BB-9DB8-7A68238D1694Q87035258-84C8D8DB-E4DD-4FC7-AE13-1AE3E292426FQ88469877-A0AB86D9-8EB1-41EA-93CE-0B620BB91DECQ91598091-F57BE362-3A84-4AFA-87EE-082ACC8C5390Q92587304-330ECF67-28D1-4DC5-BED8-0290BDF6B69C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nirmish Shah
@ast
Nirmish Shah
@en
Nirmish Shah
@es
Nirmish Shah
@nl
type
label
Nirmish Shah
@ast
Nirmish Shah
@en
Nirmish Shah
@es
Nirmish Shah
@nl
prefLabel
Nirmish Shah
@ast
Nirmish Shah
@en
Nirmish Shah
@es
Nirmish Shah
@nl
P106
P31
P496
0000-0002-7506-0935